EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Asymptomatic Cerebrospinal Fluid HIV-1 Escape: Incidence and Consequences

Gustaf Ulfhammer iD, Aylin Yilmaz iD, Åsa Mellgren, Erika Tyrberg, Erik Sörstedt iD, Lars Hagberg iD, Johanna Gostner iD, Dietmar Fuchs iD, Henrik Zetterberg iD, Staffan Nilsson, Kristina Nyström, Arvid Edén iD und 1 weitere

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiae555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Gustaf Ulfhammer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: HIV Infections, HIV-1. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Government, County Councils, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence and clinical relevance of asymptomatic cerebrospinal fluid escape (CSFE) during antiretroviral therapy (ART) is uncertain. We examined the impact and incidence of asymptomatic CSFE in a Swedish HIV cohort.

Methods

Neuroasymptomatic people with HIV (PWH) who have been on ART for at least 6 months with suppressed plasma viral load were followed longitudinally. CSFE was defined as either increased CSF HIV-1 RNA with concurrent plasma suppression or CSF HIV-1 RNA exceeding that in plasma when both were quantifiable. Paired CSF and plasma were analyzed for HIV-1 RNA, neopterin, neurofilament light protein (NfL), white blood cell (WBC) count, and albumin ratio.

Results

Asymptomatic CSFE (cutoff 50 copies/mL) was found in 4 of 173 PWH (2%) and 5 of 449 samples (1%). The corresponding proportions were 8% of PWH and 4% for samples using a 20 copies/mL cutoff for CSF HIV-1 RNA. CSFE samples (cutoff 20 copies/mL) had a 25% higher geometric mean of CSF neopterin (P = .01) and 8% higher albumin ratio (P = .04) compared to samples without CSFE. No differences were observed in CSF NfL levels (P = .8). The odds ratio for increased CSF WBC (≥ 3 cells/μL) in samples with CSFE was 3.9 (P = .004), compared to samples without elevated CSF viral load.

Conclusions

Asymptomatic CSFE was identified in only 4 (2%) PWH, with no cases of continuous CSFE observed. Increased CSF HIV-1 RNA was associated with biomarkers of CNS immune activation and blood-brain barrier impairment, but not with biomarkers of neuronal injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV-1HumansMaleFemaleViral LoadRNA, ViralAdultMiddle AgedIncidenceSwedenNeopterinLongitudinal StudiesNeurofilament ProteinsLeukocyte Count

Stichwörter der Autor:innen

HIV-1albumin ratioimmune activationneopterinneurofilament protein light

Substanzen

RNA, ViralNeopterinneurofilament protein LNeurofilament Proteins

Autor:innen und Institutionen

  • Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Institute of Medical Biochemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
  • Institute of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.

ORCID-Profile: Gustaf Ulfhammer, Aylin Yilmaz, Erik Sörstedt, Lars Hagberg, Johanna Gostner, Dietmar Fuchs, Henrik Zetterberg, Arvid Edén

Förderung

  • Swedish Government
  • County Councils
  • Swedish Research Council

Zitieren

APA

Ulfhammer, G., Yilmaz, A., Mellgren, Å., Tyrberg, E., Sörstedt, E., Hagberg, L., Gostner, J., Fuchs, D., Zetterberg, H., Nilsson, S., Nyström, K., Edén, A., & Gisslén, M. (2025). Asymptomatic Cerebrospinal Fluid HIV-1 Escape: Incidence and Consequences. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae555

Vancouver

Ulfhammer G, Yilmaz A, Mellgren Å, Tyrberg E, Sörstedt E, Hagberg L, et al. Asymptomatic Cerebrospinal Fluid HIV-1 Escape: Incidence and Consequences. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae555

BibTeX
@article{Ulfhammer2025,
  author = {Ulfhammer, Gustaf and Yilmaz, Aylin and Mellgren, Åsa and Tyrberg, Erika and Sörstedt, Erik and Hagberg, Lars and Gostner, Johanna and Fuchs, Dietmar and Zetterberg, Henrik and Nilsson, Staffan and Nyström, Kristina and Edén, Arvid and Gisslén, Magnus},
  title = {Asymptomatic Cerebrospinal Fluid HIV-1 Escape: Incidence and Consequences},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiae555}
}
Kostenlos starten →